JACKLYN STANLEY: Open Payments
NPI 1073285482 · NOBLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 20 payments from 9 companies in 2025. Trend: 2023 $693 · 2024 $390 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 3 | $46 |
| Lundbeck LLC | 2 | $46 |
| Alkermes, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: REXULTI, COBENFY, FANAPT, INGREZZA, LYBALVI, CAPLYTA, MOUNJARO, ABILIFY MAINTENA.
Industry payments across IL — which companies pay providers there.
